Form 4: BioLife Solutions CFO Sells 30,000 Shares

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 30,000 shares of common stock for approximately $25.72 per share under a pre-arranged trading plan.

Summary

• Troy Wichterman, Chief Financial Officer of BIOLIFE SOLUTIONS INC (BLFS), reported the sale of 30,000 shares of common stock.
• The transaction occurred on December 4, 2025.
• The shares were sold at a weighted average price of $25.72 per share, with individual transactions ranging from $25.53 to $25.84.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this transaction, Mr. Wichterman directly beneficially owns 152,769 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale could be perceived negatively, the disclosure that it was executed under a Rule 10b5-1 plan mitigates concerns that the sale is based on new, adverse material non-public information. It suggests a pre-scheduled personal financial planning event.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, potentially leading to short-term negative sentiment.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape. Insider transactions are common across all industries and are typically driven by individual financial planning.

Stakeholder Impact

• Shareholders may observe the insider sale and consider its implications, though the 10b5-1 plan typically reduces concerns about its signaling effect.

Key Dates

Keywords

BioLife Solutions, BLFS, Insider Transaction, Form 4, Stock Sale, CFO, Troy Wichterman, 10b5-1 Plan